LRP4 mutations promote tumor progression and resistance to anti-PD-1 therapy in recurrent hepatocellular carcinoma
Rongqi Sun(Sun Yat-sen University), Jian Zhou(Nanjing University), Shuangyi Chen(Sun Yat-sen University), Chu‐Bin Luo(Sun Yat-sen University), Long Chen(Wuhan University), Ning Li(Sun Yat-sen University), Jia Fan(Sun Yat-sen University), Yuxi Zhang(Sun Yat-sen University), Jingyue Pan(Sun Yat-sen University), Kaixuan Liu(Nanjing Tech University), Zheng‐Jun Zhou(Sun Yat-sen University), Zhiqiang Hu(Zhejiang University), Xinyi Cui(Sun Yat-sen University), Yuhang Ye(Sun Yat-sen University), Si-Yuan Pan(Sun Yat-sen University), Shao‐Lai Zhou(Sun Yat-sen University)
Cited by 5
Related Papers
Milestones in Autonomous Driving and Intelligent Vehicles: Survey of Surveys
|IEEE Transactions on Intelligent Vehicles|2022|485
microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A
|Cell Death and Disease|2018|55
<p>Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from China</p>
|Cancer Management and Research|2020|39
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
|The Lancet. Gastroenterology & hepatology|2025|39
Modified Chaihu Shugan Powder for Functional Dyspepsia: Meta-Analysis for Randomized Controlled Trial
|Evidence-based Complementary and Alternative Medicine|2013|27